Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Superoxide dismutases (SODs) are a family of metalloenzymes that catalyze the dismutation of the superoxide anion radical (O2-) into molecular oxygen (O2) and hydrogen peroxide (H2O2). This reaction is crucial for protecting cells from oxidative damage caused by reactive oxygen species (ROS). There are three main families/classes of SOD enzymes: Cu/Zn-SOD, Mn-SOD, and Fe-SOD/Ni-SOD, each with distinct metal cofactors and subcellular localizations. Mutations or dysregulation of human SODs have been linked with various diseases, including ALS and cardiomyopathy.
Catalyzes the dismutation of superoxide anion radicals into molecular oxygen and hydrogen peroxide through redox cycling of a metal cofactor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Superoxide Dismutase Enzyme Family (SOD).